Disease | eye disease |
Phenotype | C0017601|glaucoma |
Sentences | 10 |
PubMedID- 23861616 | Patients were excluded if they had concomitant eye disease, including glaucoma, uveitis, diabetic retinopathy, presence of pigment epithelial tears or rips, acute ocular or peri-ocular infection in the study eye. |
PubMedID- 23049625 | glaucoma is a group of eye diseases, characterized by progressive and irreversible structural and functional degradation of the optic nerve, with the potential to cause blindness. |
PubMedID- 21083880 | glaucoma is a group of eye diseases characterized by damage to the optic nerve that causes gradual, irreversible visual field loss. |
PubMedID- 23945288 | glaucoma is a group of eye diseases characterized by the selective and progressive death of retinal ganglion cells, which in turn, causes a severe loss in visual function. |
PubMedID- 26523231 | glaucoma, a group of eye diseases that permanently damage visual function [1], can impact patient quality of life [2] adversely [3–5]. |
PubMedID- 25108422 | glaucoma is one of the leading eye diseases due to the death of retinal ganglion cells. |
PubMedID- 25710928 | glaucoma is one of the leading eye diseases resulting in blindness due to the death of retinal ganglion cells. |
PubMedID- 25243762 | Implications for rehabilitation: glaucoma is one of the four major eye diseases that may result in visual impairment leading to disability. |
PubMedID- 23665279 | Indeed, it has been found that c1q, c1s and c3 are up-regulated during glaucoma, a form of eye disease characterised by rgc death [13], and that loss of c1q could ameliorate the severity of the disease [32]. |
PubMedID- 21323730 | glaucoma is one of the most important eye diseases resulting in blindness worldwide. |
Page: 1